Sort

Search

01/08/2025 Renal replacement therapy modalities and techniques in intensive care units: An international survey
Monard, C, Marel, A, Joannidis, M, Ostermann, M, Peng, ZY, Doi, K, De Rosa, S, Bobek, I, Sokolov, D, Wu, VC, Premuzic, V, Mehta, R, Bellomo, R, Garcia, X, Pizarro, C, Zarbock, A, Milet, I, Reis, T, Romain, M, Mc Nicholas, B, Schneider, A, Rimmelé, T. Renal replacement therapy modalities and techniques in intensive care units: An international survey. JOURNAL OF CRITICAL CARE. 2025; 88DOI:10.1016/j.jcrc.2025.155076. PMID:40179459. IF:2.900(Q2/4D).
01/08/2025 miR-30d-5p controls hyperhomocysteinemia-related atherosclerosis through the regulation of TIMP3 and MMP9
Griñán, R, Canyelles, M, Santos, D, Alonso, J, Mallén, A, Martínez-González, J, López, S, Martinez-Perez, A, Souto, JC, Soria, JM, Sanchez-Quesada, JL, Julve, J, Rodríguez, C, Hueso, M, Blanco-Vaca, F, Rotllan, N. miR-30d-5p controls hyperhomocysteinemia-related atherosclerosis through the regulation of TIMP3 and MMP9. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2025 ESR Bridges: next-generation imaging in prostate cancer-a multidisciplinary view
Panebianco, V, Catalano, C, Sanguedolce, F, De Santis, M, Padhani, AR. ESR Bridges: next-generation imaging in prostate cancer-a multidisciplinary view. EUROPEAN RADIOLOGY. 2025; 35(8)DOI:10.1007/s00330-025-11354-1. PMID:39890618. IF:4.700(Q1/2D).
01/08/2025 Current training landscape for novice robotic surgeons: an international investigative survey by the Junior-ERUS/Young academic urologists (YAU) robotics in urology working group
Wuernschimmel, C, Wenzel, M, Moschovas, MC, Dell'Oglio, P, Paciotti, M, Bravi, CA, De Groote, R, Di Maida, F, Piramide, F, Turri, F, Andras, I, Sorce, G, Liakos, N, Breda, A, Larcher, A. Current training landscape for novice robotic surgeons: an international investigative survey by the Junior-ERUS/Young academic urologists (YAU) robotics in urology working group. WORLD JOURNAL OF UROLOGY. 2025; 43(1)DOI:10.1007/s00345-025-05845-5. PMID:40748464. IF:2.900(Q2/3D).